AIRLINK 69.92 Increased By ▲ 4.72 (7.24%)
BOP 5.48 Decreased By ▼ -0.09 (-1.62%)
CNERGY 4.50 Decreased By ▼ -0.06 (-1.32%)
DFML 25.71 Increased By ▲ 1.19 (4.85%)
DGKC 70.00 Increased By ▲ 0.04 (0.06%)
FCCL 20.05 Decreased By ▼ -0.25 (-1.23%)
FFBL 30.80 Increased By ▲ 1.69 (5.81%)
FFL 9.78 Decreased By ▼ -0.05 (-0.51%)
GGL 10.13 Increased By ▲ 0.12 (1.2%)
HBL 114.80 Increased By ▲ 0.55 (0.48%)
HUBC 132.99 Increased By ▲ 3.89 (3.01%)
HUMNL 6.70 Decreased By ▼ -0.01 (-0.15%)
KEL 4.37 Decreased By ▼ -0.07 (-1.58%)
KOSM 5.02 Increased By ▲ 0.13 (2.66%)
MLCF 36.55 Decreased By ▼ -0.45 (-1.22%)
OGDC 134.20 Increased By ▲ 1.90 (1.44%)
PAEL 22.60 Increased By ▲ 0.06 (0.27%)
PIAA 25.50 Decreased By ▼ -0.39 (-1.51%)
PIBTL 6.63 Increased By ▲ 0.03 (0.45%)
PPL 113.70 Increased By ▲ 0.85 (0.75%)
PRL 29.76 Increased By ▲ 0.35 (1.19%)
PTC 14.86 Decreased By ▼ -0.38 (-2.49%)
SEARL 57.76 Increased By ▲ 0.73 (1.28%)
SNGP 66.40 Decreased By ▼ -0.05 (-0.08%)
SSGC 10.98 No Change ▼ 0.00 (0%)
TELE 8.83 Increased By ▲ 0.03 (0.34%)
TPLP 11.54 Decreased By ▼ -0.16 (-1.37%)
TRG 69.20 Increased By ▲ 0.58 (0.85%)
UNITY 23.45 Increased By ▲ 0.05 (0.21%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
BR100 7,388 Increased By 93.5 (1.28%)
BR30 24,150 Increased By 296.1 (1.24%)
KSE100 70,911 Increased By 621 (0.88%)
KSE30 23,376 Increased By 205.3 (0.89%)

Pfizer

Pfizer expands production as quarterly earnings surge to $3.5 billion
World

Pfizer expands production as quarterly earnings surge to $3.5 billion

  • Pfizer has earned $3.5 billion in the first quarter of 2021, as the ramped up sales of the COVID-19 vaccine boosted its projected annual earnings to $26 billion.
  • The American pharmaceutical company announced on Tuesday that it has raised its annual revenue guidance to up to $72.5 billion, up from $61.4 billion, predominantly due to the contractual delivery of 1.6 billion vaccine doses in 2021.
Published 05 May, 2021 10:40am
Pfizer and BioNTech request EU to approve vaccine for 12 to 15 year olds
World

Pfizer and BioNTech request EU to approve vaccine for 12 to 15 year olds

  • Pfizer and BioNTech will be seeking approval from the European Medicines Agency (EMA) to approve their coronavirus vaccine for use on 12-15 year olds.
  • The companies articulated that the children will continue to be monitored for longer-term protection and safety for an additional two years.
Updated 30 Apr, 2021 05:19pm